Former Merck CEO Ken Frazier and former American Express CEO Ken Chenault have warned companies pulling back from diversity, ...

In order to multiply the amount of plants in your garden, understanding what rooting hormones are and the types available are ...

Pfizer is already active in the protein degrader area, having partnered with Arvinas in a $2 billion-plus deal signed in 2021 ...

Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat ...

It’s similar to some major blue-chip stocks. These include the Coca-Cola Co. (KO) at $303 billion and Merck & Co. (MRK) at ...

Globally recognised as a first-line standard of care, the public funding of ERBITUX® (cetuximab) [1] marks an important development for people living with left-sided RAS wild-type and BRAF wild-type ...

COMPARED to most head and neck malignancies, the rate of throat cancer in the United States and around the globe has not declined. The statistics are also true, when extrapolated, for other countries, ...

Oncolytics Biotech is seeking accelerated approval for its lead cancer therapy, pelareorep, with plans to start a ...

No individual antipsychotic was associated with better cognitive outcomes than placebo in patients with schizophrenia spectrum disorders (SSD), according to a systematic review an ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

The FDA yesterday the approval of Novocure’s Optune device to include the treatment of metastatic non-small cell lung cancer.

Earlier in her career, Ms. Reeve held the position of Chief Financial Officer at both Inotek Pharmaceuticals and Aton Pharma, ...